|
CLDI Calidi Biotherapeutics Inc 1855485 |
| Income Statement |
|
Net Income
|
form10-q
|
-5,054,000 |
| Balance Sheet |
|
Current Assets
|
2,221,000 |
|
Assets
|
6,657,000 |
|
Current Liabilities
|
11,579,000 |
|
Liabilities
|
16,455,000 |
|
Equity
|
-9,798,000 |
|
Shares Out
|
8,084,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-14,271,000 |
|
Investing Cash Flow
|
-11,000 |
| Market Analysis |
Market Cap
|
9,248,273 |
|
Price
|
0.81 |
|
BVPS
|
1.30 |
|
PB
|
0.63 |
|
EPS
|
-5.41 |
|
PS
|
0.35 |
|
FCF
|
-14,282,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CLDI documents filed with the SEC.
CLDI Filings
Clear
